Nutraceuticals:
Resveratrol for Chronic Pain: A Patient Guide
Resveratrol is a natural polyphenol compound found in blueberries, grape skins, red wine, and peanuts. It has powerful antioxidant with anti-inflammatory properties and is helpful for mild to moderate arthritis of the knees and other joints.[1][2] It also enhances the benefits of physical activity on muscles in older individuals, improving their muscle mass and energy.[3]
See:
Nutraceutical patient Guides:
- Acetyl-L-Carnitine (ALC) for Chronic Pain: A Patient Guide
- Alpha-Lipoic Acid (ALA) for Chronic Pain: A Patient Guide
- Boswellia for Chronic Pain: A Patient Guide
- CoQ10 for Chronic Pain: A Patient Guide
- Curcumin for Chronic Pain: A Patient Guide
- Magnesium for Chronic Pain: A Patient Guide
- Melatonin for Chronic Pain: A Patient Guide
- N-Acetylcysteine (NAC) for Chronic Pain: A Patient Guide
- Nicotinamide Riboside (NAD+ Precursors) for Chronic Pain
- Omega-3 Fatty Acids for Chronic Pain: A Patient Guide
- Palmitoylethanolamide (PEA) for Chronic Pain- A Patient Guide
- Quercetin for Chronic Pain: A Patient Guide
- Resveratrol for Chronic Pain: A Patient Guide
- Sulforaphane (SFN) for Chronic Pain: A Patient Guide
- Taurine for Chronic Pain: A Patient Guide
- Vitamin D for Chronic Pain: A Patient Guide
Key to Links:
- Grey text – handout
- Red text – another page on this website
- Blue text – Journal publication
Definitions and Terms Related to Pain
Resveratrol for Chronic Pain: A Patient Guide
1. OVERVIEW
Preclinical research strongly supports the pain benefits of resveratrol, although human research remains limited.[2][4] A recent large randomized controlled trial (ARTHROL) found that oral resveratrol did not significantly reduce knee pain but the study used insufficient doses of 40mg while other smaller studies showed benefit with higher doses.[5][6] Resveratrol’s efficacy may be most pronounced when used as an adjunct therapy rather than monotherapy.
2. DIETARY SOURCES
- The amount of resveratrol in food is quite low (0.2–2 mg per serving)
- The resveratrol in food has poor bioavailability—only about 1% of what is consumed actually reaches the blood in active form[7]
- Oral absorption is approximately 75%, but extensive metabolism in the intestine and liver results in bioavailability considerably less than 1%[7]
- Nutraceutical supplements with enhanced formulations are needed to improve bioavailability
3. INDICATIONS FOR RESVERATROL SUPPLEMENTATION
Pain Conditions with Moderate to High Quality Evidence:
• Osteoarthritis (OA): Knees and hips are the best studied; evidence is mixed with some trials showing benefit as adjunctive therapy with NSAIDs, while a recent large RCT showed no benefit as monotherapy[6][5]
• Intervertebral Disc Degeneration: Preclinical evidence shows resveratrol protects nucleus pulposus cells in the inner disc and reduces disc cell apoptosis[8][9][10]
4. RESVERATROL’S IMPACT ON PAIN CONDITIONS
Resveratrol impacts damaged or dysfunctional tissues through multiple mechanisms:
- Osteoarthritis: Resveratrol inhibits inflammatory responses, protects chondrocytes, maintains cartilage homeostasis, and promotes autophagy.[1] It reduces levels of matrix metalloproteinases (MMP-1, MMP-3, MMP-13) that degrade cartilage and increases aggrecan (a key cartilage component).[11][9] These effects are mediated through regulation of NF-κB, TLR4, and SIRT1 signaling pathways.[1]
- Intervertebral Disc Degeneration: Resveratrol protects nucleus pulposus cells from oxidative stress-induced apoptosis and mitochondrial dysfunction.[8] It reduces inflammatory cytokine-induced annulus fibrosus cell death and promotes disc cell survival.[9][10] In animal models, resveratrol injection effectively retards the degenerative process of intervertebral discs.[8]
5. RESVERATROL’S IMPACT ON PAIN PROCESSING
Pain processing refers to how pain signals travel from the initial damaged tissue through the nerves and spinal cord to the brain and back down again. For resveratrol, pain processing mechanisms appear to be the dominant therapeutic target, with more consistent evidence supporting its effects on neuroinflammation, oxidative stress, and central sensitization than on direct tissue repair.[4]
• Level 1 – Peripheral Pain Receptor (Nociception Transduction): Resveratrol regulates primary receptors in dorsal root sensory neurons and inhibits voltage-gated ion channels involved in pain signal initiation[4][12]
• Level 2 – Primary Afferent Transmission to Spinal Cord: Resveratrol reduces inflammatory mediators at peripheral sites that sensitize nerve fibers transmitting pain signals[13]
• Level 3 – Spinal Cord Dorsal Horn Processing (First Synapse): Resveratrol attenuates spinal microglia activation and reduces inflammatory compounds (IL-1β, IL-6, TNF-α) in the spinal dorsal horn.[14][15] It suppresses neuroinflammation by inhibiting JAK2/STAT3 signaling[15]
• Level 4 – Ascending Spinal Pathways and Supraspinal Processing: Resveratrol modulates the TREM2-autophagy axis in the spinal cord, reducing neuroinflammation that affects ascending pain pathways[14]
• Level 5 – Brain Cortical Processing and Pain Perception: Resveratrol reduces inflammation and increases pCREB and BDNF expression in the hippocampus, which may alleviate pain-related anxiety[16]
• Level 6 – Descending Pain Modulation: Resveratrol enhances IL-4 receptor-mediated anti-inflammatory effects in the spinal cord, potentially strengthening descending inhibitory pain control[17]
6. BENEFITS FOR PAIN SENSITIZATION
• Peripheral Sensitization: Rating of LOW quality evidence due to lack of human studies; preclinical data shows resveratrol reduces peripheral inflammatory mediators (COX-2, iNOS, cytokines) that cause sensitization[13]
• Central Sensitization: Rating of LOW quality evidence due to lack of human studies; preclinical evidence demonstrates resveratrol suppresses spinal microglia-mediated neuroinflammation and reduces central sensitization markers[14][17]
7. RESVERATROL’S IMPACT ON THE 4 DRIVING FORCES OF CHRONIC PAIN
1. Systemic Inflammation: Resveratrol has robust evidence for reducing inflammation both in pain processing in the nervous system and in local tissues in joints. It reduces proinflammatory cytokines (IL-6, IL-8, TNF-α) and increases anti-inflammatory cytokines through modulation of NF-κB and AP-1 transcription factors. It is cardioprotective, hepatoprotective, neuroprotective, and has anticancer properties.[6][18][19]
2. Neuroinflammation: Resveratrol reduces inflammatory compounds in the spinal cord that impact pain processing, thereby suppressing the development of central sensitization. It regulates microglia M1/M2 polarization, shifting from proinflammatory M1 to anti-inflammatory M2 phenotype via PGC-1α activation. It also modulates formyl peptide receptor (FPR1) expression, leading to amelioration of neuroinflammation.[14][20][21]
3. Oxidative Stress: Resveratrol is a potent antioxidant that activates multiple pathways (including Nrf2) that enhance the body’s natural antioxidant defense systems. It reduces lipid peroxidation and increases glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) activities.[4][22]
4. Mitochondrial Dysfunction: Resveratrol promotes new growth of mitochondria (mitochondrial biogenesis). In intervertebral disc cells, resveratrol protects against oxidative stress-induced mitochondrial dysfunction through autophagy activation.[19][8]
8. DOSING, TIMING, DURATION AND ADMINISTRATION
• Dosing: For most conditions, 250–500 mg/day is commonly used; doses up to 1,000 mg/day are generally well tolerated.[23][24] A meta-analysis suggests doses of 100–500 mg provide appropriate plasma concentrations with very low risk of side effects[23]
• Administration: Take with meals—but not high-fat meals, which may impair absorption
• Frequency: Can be taken once daily or split into two doses (morning and evening)
• When to Expect Results: Within 2–4 weeks, but may require 8–12 weeks of consistent use
• Duration: Long-term use appears safe; no significant increase in toxicity with longer-term intake[25]
9. FORMULATION CONSIDERATIONS
• Trans-resveratrol: This is the active form—avoid cis-resveratrol[26]
• Micronized Resveratrol: Smaller particles absorb better and cross into the brain and spinal cord to reduce neuroinflammation and central sensitization; these formulations are preferred for chronic pain[19]
• Lipid-based formulations: Products using lipid dispersion technology (e.g., LipiSperse) increase absorption 2–3 fold, but may not penetrate into the nervous system as well as micronized formulations[26]
• Phospholipid complexes: Can improve bioavailability by enhancing water solubility[27]
10. SYNERGIES WITH OTHER PAIN MEDICATIONS AND NUTRACEUTICALS
Resveratrol works synergistically with:
• Curcumin (turmeric): Both target similar but different inflammatory pathways
• Omega-3 fatty acids: Offer anti-inflammatory benefits through different mechanisms
• Vitamin D: May supplement anti-inflammatory benefits
• NSAIDs: When combined with meloxicam/Mobic, it reduces pain and inflammation in knee OA[6]
• Opioids: May enhance the body’s natural opioids (endorphins) to reduce pain
• Cannabinoids: May enhance the body’s natural endocannabinoids’ anti-inflammatory benefits
• Exercise: Studies show resveratrol, when combined with exercise, enhances improvement in muscle mass, muscle function, and physical performance in older adults[3]
11. DRUG INTERACTIONS
Resveratrol may increase blood levels of these medications through CYP450 enzyme inhibition:[28][29]
• Warfarin (blood thinner): Monitor blood levels (INR)—resveratrol inhibits CYP3A4/5 which may affect warfarin metabolism
• Statins (cholesterol medications): Monitor for muscle pain
• Benzodiazepines (Valium, Xanax, Klonopin, etc.): Monitor for drowsiness
• CYP3A4 substrates: Resveratrol significantly inhibits CYP3A4/5 activity by a non-competitive mechanism, suggesting potential risk of drug interactions[28]
12. SAFETY AND CONTRAINDICATIONS
Safety:
• Common side effects: GI symptoms (nausea, diarrhea) at high doses (>1 g/day)[30]
• Serious side effects: Rare, associated with high doses[31]
• Generally well tolerated at doses up to 1 g/day[24]
• An acceptable daily intake (ADI) of 450 mg/day has been established based on safety studies[25]
• No significant adverse events reported in older adult studies[3]
Contraindications:
• Pregnancy/lactation
• Severe liver impairment
• High-dose anticoagulation
• Caution with medications metabolized by CYP3A4
13. SPECIAL CONSIDERATIONS / TIPS
• Storage: Resveratrol may be sensitive to light and heat; store in a cool, dry place in opaque bottles
• Timing with food: Take with meals for better absorption, but avoid high-fat meals
• Patience required: Benefits may take 8–12 weeks to become apparent
• Adjunctive use: Evidence suggests resveratrol may be more effective when combined with other therapies (NSAIDs, exercise) rather than as monotherapy[6][3]
• Formulation matters: Choose trans-resveratrol in micronized or lipid-based formulations for better bioavailability
14. COSTS
Resveratrol supplements vary widely in price depending on formulation and brand. Enhanced bioavailability formulations (micronized, lipid-based) typically cost more than standard preparations. Generic trans-resveratrol supplements are generally affordable and widely available.
—
References
- The Role and Current Research Status of Resveratrol in the Treatment of Osteoarthritis and Its Mechanisms: A Narrative Review. Zou X, Xu H, Qian W. Drug Metabolism Reviews. 2024;56(4):399-412. doi:10.1080/03602532.2024.2402751.
- Protective Effect of Resveratrol on Knee Osteoarthritis and Its Molecular Mechanisms: A Recent Review in Preclinical and Clinical Trials. Yang S, Sun M, Zhang X. Frontiers in Pharmacology. 2022;13:921003. doi:10.3389/fphar.2022.921003.
- Effects and Safety of Resveratrol Supplementation in Older Adults: A Comprehensive Systematic Review. Yadegar S, Mohammadi F, Yadegar A, et al. Phytotherapy Research : PTR. 2024;38(5):2448-2461. doi:10.1002/ptr.8171.
- Deciphering Resveratrol’s Role in Modulating Pathological Pain: From Molecular Mechanisms to Clinical Relevance. Wang B, Jiang HM, Qi LM, et al. Phytotherapy Research : PTR. 2024;38(1):59-73. doi:10.1002/ptr.8021.
- Oral Resveratrol in Adults With Knee Osteoarthritis: A Randomized Placebo-Controlled Trial (ARTHROL). Nguyen C, Coudeyre E, Boutron I, et al. PLoS Medicine. 2024;21(8):e1004440. doi:10.1371/journal.pmed.1004440.
- Resveratrol Supplementation Reduces Pain and Inflammation in Knee Osteoarthritis Patients Treated With Meloxicam: A Randomized Placebo-Controlled Study. Marouf BH, Hussain SA, Ali ZS, Ahmmad RS. Journal of Medicinal Food. 2018;. doi:10.1089/jmf.2017.4176.
- Bioavailability of Resveratrol. Walle T. Annals of the New York Academy of Sciences. 2011;1215:9-15. doi:10.1111/j.1749-6632.2010.05842.x.
- Resveratrol Protects Against Mitochondrial Dysfunction Through Autophagy Activation in Human Nucleus Pulposus Cells. Zhang B, Xu L, Zhuo N, Shen J. Biochemical and Biophysical Research Communications. 2017;493(1):373-381. doi:10.1016/j.bbrc.2017.09.015.
- The Action of Resveratrol, a Phytoestrogen Found in Grapes, on the Intervertebral Disc. Li X, Phillips FM, An HS, et al. Spine. 2008;33(24):2586-95. doi:10.1097/BRS.0b013e3181883883.
- Resveratrol Suppresses Annulus Fibrosus Cell Apoptosis Through Regulating Oxidative Stress Reaction in an Inflammatory Environment. Shan Q, Li N, Zhang F, Yu P, Meng Q. BioMed Research International. 2021;2021:9100444. doi:10.1155/2021/9100444.
- Effect of Resveratrol on Serum Levels of Type II Collagen and Aggrecan in Patients With Knee Osteoarthritis: A Pilot Clinical Study. Marouf BH. BioMed Research International. 2021;2021:3668568. doi:10.1155/2021/3668568.
- Modulatory Mechanism of Nociceptive Neuronal Activity by Dietary Constituent Resveratrol. Takeda M, Takehana S, Sekiguchi K, Kubota Y, Shimazu Y. International Journal of Molecular Sciences. 2016;17(10):E1702. doi:10.3390/ijms17101702.
- Anti-Nociceptive Effect of Resveratrol During Inflammatory Hyperalgesia via Differential Regulation of Pro-Inflammatory Mediators. Singh AK, Vinayak M. Phytotherapy Research : PTR. 2016;30(7):1164-71. doi:10.1002/ptr.5624.
- Resveratrol Mediates Mechanical Allodynia Through Modulating Inflammatory Response via the TREM2-autophagy Axis in SNI Rat Model. Wang Y, Shi Y, Huang Y, et al. Journal of Neuroinflammation. 2020;17(1):311. doi:10.1186/s12974-020-01991-2.
- Resveratrol Suppresses Neuroinflammation to Alleviate Mechanical Allodynia by Inhibiting Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Signaling Pathway in a Rat Model of Spinal Cord Injury. Han J, Hua Z, Yang WJ, et al. Frontiers in Molecular Neuroscience. 2023;16:1116679. doi:10.3389/fnmol.2023.1116679.
- Resveratrol-Enhanced SIRT1-mediated Osteogenesis in Porous Endplates Attenuates Low Back Pain and Anxiety Behaviors. Lv X, Chen S, Gao F, et al. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. 2021;35(3):e21414. doi:10.1096/fj.202002524R.
- Resveratrol Enhances IL-4 Receptor-Mediated Anti-Inflammatory Effects in Spinal Cord and Attenuates Neuropathic Pain Following Sciatic Nerve Injury. Xu M, Cheng Z, Ding Z, et al. Molecular Pain. 2018 Jan-Dec;14:1744806918767549. doi:10.1177/1744806918767549.
- Exploring New Ways of Regulation by Resveratrol Involving miRNAs, With Emphasis on Inflammation. Latruffe N, Lançon A, Frazzi R, et al. Annals of the New York Academy of Sciences. 2015;1348(1):97-106. doi:10.1111/nyas.12819.
- Health Benefits of Resveratrol: Evidence From Clinical Studies. Singh AP, Singh R, Verma SS, et al. Medicinal Research Reviews. 2019;39(5):1851-1891. doi:10.1002/med.21565.
- Resveratrol Regulates Microglia M1/M2 Polarization via PGC-1α in Conditions of Neuroinflammatory Injury. Yang X, Xu S, Qian Y, Xiao Q. Brain, Behavior, and Immunity. 2017;64:162-172. doi:10.1016/j.bbi.2017.03.003.
- Formyl Peptide Receptor (FPR)1 Modulation by Resveratrol in an LPS-Induced Neuroinflammatory Animal Model. Calvello R, Cianciulli A, Porro C, et al. Nutrients. 2021;13(5):1418. doi:10.3390/nu13051418.
- Resveratrol Inhibition of the WNT/β-Catenin Pathway Following Discogenic Low Back Pain. Genovese T, Impellizzeri D, D’Amico R, et al. International Journal of Molecular Sciences. 2022;23(8):4092. doi:10.3390/ijms23084092.
- Resveratrol Bioavailability After Oral Administration: A Meta-Analysis of Clinical Trial Data. Szymkowiak I, Marcinkowska J, Kucinska M, Regulski M, Murias M. Phytotherapy Research : PTR. 2025;39(1):453-464. doi:10.1002/ptr.8379.
- Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities. Brown K, Theofanous D, Britton RG, et al. International Journal of Molecular Sciences. 2024;25(2):747. doi:10.3390/ijms25020747.
- Safety of Resveratrol With Examples for High Purity, Trans-Resveratrol, resVida(®). Edwards JA, Beck M, Riegger C, Bausch J. Annals of the New York Academy of Sciences. 2011;1215:131-7. doi:10.1111/j.1749-6632.2010.05855.x.
- Trans-Resveratrol Oral Bioavailability in Humans Using LipiSperse™ Dispersion Technology. Briskey D, Rao A. Pharmaceutics. 2020;12(12):E1190. doi:10.3390/pharmaceutics12121190.
- Dual Strategy for Improving the Oral Bioavailability of Resveratrol: Enhancing Water Solubility and Inhibiting Glucuronidation. Li Y, Zhang R, Zhang Q, et al. Journal of Agricultural and Food Chemistry. 2021;69(32):9249-9258. doi:10.1021/acs.jafc.1c02602.
- Trans-Resveratrol, but Not Other Natural Stilbenes Occurring in Food, Carries the Risk of Drug-Food Interaction via Inhibition of Cytochrome P450 Enzymes or Interaction With Xenosensor Receptors. Hyrsova L, Vanduchova A, Dusek J, et al. Toxicology Letters. 2019;300:81-91. doi:10.1016/j.toxlet.2018.10.028.
- Drug Interaction Potential of Resveratrol. Detampel P, Beck M, Krähenbühl S, Huwyler J. Drug Metabolism Reviews. 2012;44(3):253-65. doi:10.3109/03602532.2012.700715.
- Review of Recent Data on the Metabolism, Biological Effects, and Toxicity of Resveratrol in Humans. Cottart CH, Nivet-Antoine V, Beaudeux JL. Molecular Nutrition & Food Research. 2014;58(1):7-21. doi:10.1002/mnfr.201200589.
- Potential Adverse Effects of Resveratrol: A Literature Review. Shaito A, Posadino AM, Younes N, et al. International Journal of Molecular Sciences. 2020;21(6):E2084. doi:10.3390/ijms21062084.
Emphasis on Education
Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.
For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.
Should you wish more information regarding any of the subjects listed – or not listed – here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.
For more information, please contact Accurate Clinic.
Supplements recommended by Dr. Ehlenberger may be purchased commercially online
Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.
.
